Streetbeat News

Products Services

MOB

Mobilicom Limited (NASDAQ:MOB) has secured two follow-on orders, including one from a large Tier-1 customer. The orders are for Mobilicom's Mesh networking product and Mobile Ground Control Stations, demonstrating market traction for the company's solutions in drones and military settings. The repeat orders come from a Tier-1 global leader in the defense and aerospace market and a maker of remote controlled weapons stations.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 1:13 pm

NTRA

Natera, Inc. (NASDAQ:NTRA) will present new data on its molecular residual disease (MRD) test, Signatera, at the 2023 European Society for Medical Oncology (ESMO) Congress. The data includes an updated analysis of over 2,000 patients from the GALAXY observational arm of the CIRCULATE-Japan trial, one of the largest studies of MRD testing in resectable colorectal cancer. Other presentations will highlight new Signatera data in various types of cancer.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 1:08 pm

IMMX

Immix Biopharma has successfully completed the third engineering batch of NXC-201 at its U.S. CAR-T manufacturing site. This completion supports the expansion of its ongoing NEXICART-1 (NCT04720313) NXC-201 CAR-T clinical trial to the U.S.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 1:06 pm

AAPL

Apple has announced the expansion of its online store in Chile, allowing customers to shop Apple's full lineup of products and services. The online store offers benefits such as product personalization, fast and free delivery, and a range of affordability options with flexible financing plans and the Apple Trade In program. The new iPhone 15 and Apple Watch Series 9 are among the products available for pre-order from October 20.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 1:04 pm

ACHR

Archer Aviation Inc. (ACHR) and Abu Dhabi Investment Office (ADIO) have announced a plan to launch Archer's all-electric air taxi service across the UAE. The service is expected to start in 2026. ADIO will support Archer's launch through incentives. Archer will also build an engineering Center of Excellence to support the advanced air mobility industry in the UAE and the Middle East. Archer has raised over $1.1 billion of funding to date, including investments from Mubadala Capital, United Airlines, Stellantis, and Boeing.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 1:04 pm

FTNT

GOOG

Fortinet has expanded its global Secure Access Service Edge (SASE) points-of-presence through a partnership with Google Cloud. This allows Fortinet to leverage Google Cloud's global network edge locations, which offer dedicated interconnect and 99.99% service availability, to accelerate the expansion of Fortinet's Universal SASE solution.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 1:04 pm

ERIC

Ericsson (NASDAQ:ERIC) has been selected by Appalachian Wireless, an East Kentucky Network (EKN) company, for a multi-year Radio Access Network (RAN) modernization project to bring 5G technologies to underserved communities in Appalachia. The project will expand Ericsson's 5G capacity and coverage and replace aging RAN equipment with Ericsson Radio System solutions. The majority of the modernization efforts will take place in 2023 and 2024.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 1:03 pm

FBIO

Fortress Biotech's subsidiary, Helocyte, has secured an option agreement with City of Hope for exclusive worldwide rights to use a novel bispecific CMV/HIV CAR T Cell Therapy for HIV-1 treatment. The therapy has shown promising results in preclinical studies, eradicating HIV from latent reservoirs. The California Institute for Regenerative Medicine (CIRM) has granted $11.3 million to fund the Phase 1 clinical trial at City of Hope, which has been accepted by the FDA.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 1:02 pm

MRNA

Moderna has stated that it remains comfortable with its projected range of $6B-$8B in anticipated revenues from the sale of its Covid-19 vaccine for the full year 2023.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 1:01 pm

HUMA

Humacyte has published preclinical results showing the patency of its Human Acellular Vessel as a modified Blalock–Taussig–Thomas shunt in a juvenile primate model.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:59 pm